The clinical utility of the 70 gene signature MammaPrint has been evaluated in a prospective randomized trial MINDACT, 14 which included 6, 693 women with node negative or 1 3 node positive, early stage breast cancer priligy amazon
The clinical utility of the 70 gene signature MammaPrint has been evaluated in a prospective randomized trial MINDACT, 14 which included 6, 693 women with node negative or 1 3 node positive, early stage breast cancer priligy amazon
Leave a comment